These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2674444

  • 1. Localisation and physiological effects of tissue renin-angiotensin systems.
    Swales JD, Samani NJ.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():71-7. PubMed ID: 2674444
    [Abstract] [Full Text] [Related]

  • 2. Vascular RAA system.
    Swales JD, Samani NJ.
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S3-6. PubMed ID: 8230086
    [Abstract] [Full Text] [Related]

  • 3. [The current concept of the renin-angiotensin system].
    Ibarra-Rubio ME, Pedraza-Chaverrí J.
    Rev Invest Clin; 1993 Aug; 45(2):165-77. PubMed ID: 8337545
    [Abstract] [Full Text] [Related]

  • 4. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW, Resink TJ, Mackie E, Scott-Burden T, Bühler FR.
    Am J Med; 1993 Apr 23; 94(4A):13S-19S. PubMed ID: 8488851
    [Abstract] [Full Text] [Related]

  • 5. Intracardiac generation of angiotensin and its physiologic role.
    Lindpaintner K, Jin M, Wilhelm MJ, Suzuki F, Linz W, Schoelkens BA, Ganten D.
    Circulation; 1988 Jun 23; 77(6 Pt 2):I18-23. PubMed ID: 3286043
    [Abstract] [Full Text] [Related]

  • 6. Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control.
    Dzau VJ.
    J Hypertens Suppl; 1988 Dec 23; 6(3):S7-12. PubMed ID: 3066879
    [Abstract] [Full Text] [Related]

  • 7. RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure.
    Seravalle G, Cattaneo BM, Giannattasio C, Perondi R, Saino A, Grassi G, Mancia G.
    J Hum Hypertens; 1993 Aug 23; 7 Suppl 2():S13-8. PubMed ID: 8230084
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z, Armaly Z, Nakhoul F, Hoffman A.
    Harefuah; 2008 Jun 23; 147(6):536-42, 573. PubMed ID: 18693632
    [Abstract] [Full Text] [Related]

  • 12. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Jun 23; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P, Leite-Moreira AF.
    Rev Port Cardiol; 2004 May 23; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [Abstract] [Full Text] [Related]

  • 15. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr 23; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 16. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD.
    J Cardiovasc Pharmacol; 1994 Apr 23; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma renin activity and changes in tissue angiotensin converting enzyme.
    Michel B, Grima M, Stephan D, Coquard C, Welsch C, Barthelmebs M, Imbs JL.
    J Hypertens; 1994 May 23; 12(5):577-84. PubMed ID: 7930558
    [Abstract] [Full Text] [Related]

  • 19. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
    Cooper ME.
    Am J Hypertens; 2004 Nov 23; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
    [Abstract] [Full Text] [Related]

  • 20. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y, Franco-Saenz R, Mulrow PJ.
    Am J Hypertens; 1995 Oct 23; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.